Clarametyx Biosciences Inc. is a preclinical stage biotechnology company developing immune-enabling biologic therapies to fight life-threatening infections. Our novel technology platform targets the protective barrier around bacteria, known as biofilms.
Location: United States, Ohio, Columbus
Employees: 11-50
Total raised: $33M
Founded date: 2020
Investors 2
| Date | Name | Website |
| - | Ohio Innov... | ohioinnova... |
| - | CARB-X | carb-x.org |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 06.01.2024 | Series A | $33M | - |
Mentions in press and media 4
| Date | Title | Description |
| 29.01.2025 | Clarametyx Biosciences Receives Investment From Kineticos AMR Accelerator Fund | Clarametyx Biosciences, a Columbus, OH-based clinical stage company developing targeted, immune-enabling biologic therapies to counter persistent infections associated with biofilms, received an investment from Kinetics AMR Accelerator Fund... |
| 06.01.2024 | Clarametyx Biosciences Raises $33M in Series A Financing | Clarametyx Biosciences, a Columbus, OH-based clinical stage company developing targeted, immune-enabling biologic therapies to counter persistent infections associated with biofilms, raised $33M in Series A funding. The round was led by Ohi... |
| 20.12.2021 | Clarametyx Biosciences Awarded $3.15 Million Grant From NIH to Advance a Broad-Spectrum Vaccine Technology for Bacterial Infections | Clarametyx Biosciences Inc. (“Clarametyx”), a late preclinical stage biotechnology company developing targeted, immune-enabling biologic therapies to counter persistent infections associated with biofilms, today announced the receipt of a g... |
| - | Clarametyx Biosciences | “Clarametyx Home - Clarametyx Biosciences” |